NSC | Compound | Enrichment | Correlation |
---|---|---|---|
NSC 751152 | 3-(6/7-trifluoro-3-methyl-1,4-dioxy-quinoxaline-2-yl)-1-(3,4,5-trimethoxy-phenyl)-propenone | 0.0202245331784477 | -0.32464601 |
NSC 109834 | Null | 0.0202245331784478 | -0.33908327 |
NSC 276371 | 2,5-Cyclohexadiene-1,4-dione, 2,3-dimethoxy-5-[(3,7,11,15-tetramethyl-2-hexadecenyl)thio]-, [R-[R*,R*-(E)]]- | 0.0202245331784478 | -0.021964903 |
NSC 295500 | Camptothecin Derivative | 0.0202245331784478 | 0.045554872 |
NSC 305782 | 2,4-Quinazolinediamine, 6-[[3-(trifluoromethyl)phenyl]thio]- | 0.0202245331784478 | -0.24104097 |
NSC 361127 | DESTRUXIN E | 0.0202245331784478 | -0.16663194 |
NSC 364170 | 3,13-Ethano-1H,10H-furo[3,4-c]furo[2',3':6,7]naphtho[2,3-b]pyran-3(3aH)-carboxylic acid, 4,5,6a,7,7a,8,12a,13-octahydro-4,14,15-trihydroxy-8,12a-dimethyl-5,10-dioxo-, methyl ester, [3S-(3.alpha.,3a.a | 0.0202245331784478 | 0.0031691521 |
NSC 625741 | Null | 0.0202245331784478 | -0.12171718 |
NSC 632855 | 9-Chloro-2-methylellipticinium acetate, hydrate | 0.0202245331784478 | 0.41976413 |
NSC 645991 | Null | 0.0202245331784478 | -0.27975112 |